Vertaling van "gamma-e globulin " (Engels → Frans) :

TERMINOLOGIE

immunoglobulin E | IgE | gamma-E globulin
immunoglobulines E | IgE | IgND

gamma globulin | immunoglobulin G | immunoglobulin gamma | IgG [Abbr.]
gamma globuline | gammaglobuline | immunoglobuline G | IgG [Abbr.]

lyophilised gamma-globulin
gammaglobuline lyophilisée

gamma globulin prophylaxis
prophylaxie par la gammaglobuline

Gamma globulin serum
sérum de gammaglobuline

The non-syndromic form of a primary immunodeficiency disease characterized by deficient gamma globulins and associated predisposition to frequent and recurrent infections from infancy. Two forms have been described: X-linked represents approximately
agammaglobulinémie isolée

The non-syndromic form of a primary immunodeficiency disease characterised by deficient gamma globulins and associated predisposition to frequent and recurrent infections from infancy. Two forms have been described: X-linked represents approximately
hypogammaglobulinémie isolée

gamma globulin [ gammaglobulin | human gamma globulin ]
gammaglobuline [ gamma-globuline | gamma globuline humaine ]

gamma globulin | γ-globulin | y-g | gammaglobulin
gammaglobuline | y-globuline

human gamma globulin | HGG | human gammaglobulin | human immunoglobulin | human immune globulin
gammaglobuline humaine | GGH | immunoglobuline humaine

IN-CONTEXT TRANSLATIONS

Dispense 100 μl/well of horseradish-peroxidase (HRP) -conjugated anti-horse gamma-globulin diluted in PBS + 5 % milk + 0,05 % Tween 20, pH 7,2.
Déposer 100 μl/puits des anticorps anti-cheval conjugués à la peroxydase de raifort; ces anticorps sont dilués dans une SSTP + 5 % de lait écrémé + 0,05 % de Tween-20 de pH 7,2.

As regards stable blood products (gamma globulins, anti-haemophilic factors, etc.) this practice contravenes Regulation 2309/93 which no longer allows Member States to oppose the placing on their national markets of medicinal products covered by a Community authorisation.
En ce qui concerne les dérivés stables du sang (gamma globulines, facteurs anti hémophiliques...) cette pratique fait échec au règlement 2309/93 qui ne permet plus aux Etats membres de s'opposer à la mise sur leur marché national de médicaments munis d'une autorisation communautaire.